Insider plans sale of 6,622 MPLT shares

Robert Malenka has filed a Form 144 notice to sell 6,622 shares of MPLT common stock.

Rhea-AI Filing Summary

Robert Malenka has filed a Form 144 notice to sell 6,622 shares of MPLT common stock. The shares were acquired on 01/23/2026 through restricted stock vesting under a registered plan, as payment for services rendered.

The planned sale, with an aggregate market value of $119,962.83, is to be executed through Morgan Stanley Smith Barney LLC on or around 02/10/2026 on the NASDAQ exchange. MPLT had 45,373,033 common shares outstanding at the time listed. Over the prior three months, Malenka reported several MPLT common stock sales totaling tens of thousands of shares and several hundred thousand dollars in gross proceeds.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does MPLT's Form 144 filed by Robert Malenka disclose?

The Form 144 shows that Robert Malenka plans to sell 6,622 shares of MPLT common stock. These shares were acquired on 01/23/2026 through restricted stock vesting under a registered plan as compensation for services, and the sale is to be executed through Morgan Stanley Smith Barney LLC.

How many MPLT shares does Robert Malenka plan to sell under this Form 144?

Robert Malenka plans to sell 6,622 shares of MPLT common stock. The filing lists an aggregate market value of $119,962.83 for these shares, with the transaction expected around 02/10/2026 on NASDAQ through Morgan Stanley Smith Barney LLC Executive Financial Services.

What previous MPLT stock sales by Robert Malenka are reported in the last 3 months?

The filing reports several MPLT common stock sales by Robert Malenka over the past three months, including 21,262 shares on 01/29/2026 and 7,039 shares on 02/02/2026, among others. Gross proceeds from these sales range from $18.00 to $394,469.63 per listed transaction.

How were the MPLT shares in Robert Malenka’s planned Form 144 sale acquired?

The 6,622 MPLT shares were acquired on 01/23/2026 as restricted stock vesting under a registered plan. The filing states the consideration as “Services Rendered,” indicating the shares were granted as compensation rather than purchased for cash on the acquisition date.

What share count and trading venue for MPLT are referenced in this Form 144?

The notice references 45,373,033 MPLT common shares outstanding and identifies NASDAQ as the securities exchange for the planned sale. Morgan Stanley Smith Barney LLC Executive Financial Services is listed as the broker handling the 6,622-share transaction for Robert Malenka.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/10/2026 - 04:22 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0002021198
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	MAPLIGHT THERAPEUTICS, INC.
SEC File Number	001-42914
Address of Issuer	800 Chesapeake Drive Redwood City CALIFORNIA 94063
Phone	(617) 984-6300
Name of Person for Whose Account the Securities are To Be Sold	ROBERT MALENKA
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	6622	119962.83	45373033	02/10/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	01/23/2026	Restricted stock vesting under a registered plan	Issuer			6622	01/23/2026	Services Rendered

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
ROBERT MALENKA 800 Chesapeake Drive Redwood City CA 94063	Common	02/03/2026	1	18.00
ROBERT MALENKA 800 Chesapeake Drive Redwood City CA 94063	Common	02/02/2026	7039	126835.04
ROBERT MALENKA 800 Chesapeake Drive Redwood City CA 94063	Common	01/30/2026	6612	119736.71
ROBERT MALENKA 800 Chesapeake Drive Redwood City CA 94063	Common	01/29/2026	21262	394469.63
ROBERT MALENKA 800 Chesapeake Drive Redwood City CA 94063	Common	01/28/2026	6524	121689.56

144: Remarks and Signature

Remarks
Date of Notice	02/10/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Robert Malenka
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)